In gastric cancer (GC), Wang et al. found that METTL3 increased the m6A modification of HDGF mRNA to promote its expression, and IGF2BP3 further maintained the stability of HDGF mRNA, which in turn activated GLUT4 and ENO2 to enhance glycolysis53. Here, ENO2 is linked to gastric cancer.